Yi Lin ,Ph.D. Managing Partner


    MBA from University of Chicago; PhD in molecular biology from Medical College of Columbia Univ.; Bachelor in biology from Peking University

Work Experience

    Successful industrial experience, medicine and medical device investment fund investment and management experience. 

     River Head Capital: Executive Director 

    Founder Korea Investment: Managing Director 

    ePlanet Ventures: Chinese Partners
    Mingly China Growth Fund: Executive Director
    Eastwin Life Sciences: Co-founder & director 

    McKinsey:  Senior Consultant

Investment Cases

    Drug Discovery: RC-Pharmaceutical, PegBio Medicine, Yinglian Biopharmaceutical, Sorrento Pharmaceutical (Nasdaq: SRNE), EOC 

    Medical services: IKANG  (exited), Huayi Webz (exited), BeauCare Clinics,
    Medical devices: Family of Health (exited), Alltech Medical (exited), Muenster Medicine, Yongyuan Medicine 

    IVD: CaptialBio, Life Real, Shuwen, Wuhan Healthcare, iShine,